CLINICAL_TRIALS
trial_result
· 2020-02-21
Clinical Trial Update: A Phase ll Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis [Phase 2]
Summary
A Phase 2 clinical trial of IMM-124E for non-alcoholic steatohepatitis has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Immuron Ltd. | Conditions: Non-alcoholic Steatohepatitis (NASH) | Phase 2 | Status: COMPLETED | Results posted: 2020-02-21